Saliva swab could spot hidden virus in kids
NCT ID NCT00815802
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a simple saliva test can find cytomegalovirus (CMV) in children aged 3 months to 6 years. Researchers collected saliva samples from 655 children in daycares and a hospital emergency department. The goal was to see how common the virus is and to check if the testing process works well.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
655 people
The number who actually took part.
- Start date
-
Jul 2007
- Completion date
-
Sep 2014
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
child aged from 3 month to 6 years in day care centers or in emergency department.
- Ages
-
3 months to 6 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * parents consent * child aged from 3months to 6 years * child in day care centers or emergency department Exclusion Criteria: * Refuse of participation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cytomegalovirus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bactériologie-Virologie
Limoges, 87, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Moderna's mRNA vaccine cocktail passes early safety check
- Immune cells from donors may tame stubborn viruses in transplant kids
- 10,000 people tested: Cambodia's massive disease hunt begins
- Immune cells from donors take on viruses in transplant patients
- New hope for transplant patients: study aims to block dangerous late-stage virus
- New mRNA vaccine aims to shield teens and young adults from common virus